Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
23.5 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
75
Modified dose descriptor starting point:
NOAEC
Value:
1 763 mg/m³
Explanation for the modification of the dose descriptor starting point:
assuming 10% absorption via oral and 10% via inhalative route the NOAEL of 1000 mg/kg bw/d from a subacute oral study is corrected by multiplying with 10/10 and division by 0.38 m3/kg for air consumption and multiplication with 6.7/10 for light work adjustment --> NOAECcorr = 1000 mg/kg bw/d * 10/10 * 6.7/10 / 0.38 m3/kg/d = 1763 mg/m3
AF for dose response relationship:
1
Justification:
NOAEC used as starting point
AF for differences in duration of exposure:
6
Justification:
based on the subacute study
AF for interspecies differences (allometric scaling):
1
Justification:
not required due to route-to-route extrapolation
AF for other interspecies differences:
2.5
Justification:
default factor for remaining differences
AF for intraspecies differences:
5
Justification:
for worker, a default AF of 5 is to be used
AF for the quality of the whole database:
1
Justification:
not required
AF for remaining uncertainties:
1
Justification:
not required
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
3.33 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
300
Modified dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
oral to dermal, assuming 10% oral absorption and 10% dermal absorption and thereby corrected by multiplying with 10/10
AF for dose response relationship:
1
Justification:
NOAEL is used as the starting point
AF for differences in duration of exposure:
6
Justification:
based on the subacute study
AF for interspecies differences (allometric scaling):
4
Justification:
rats are used in the animal test
AF for other interspecies differences:
2.5
Justification:
no other substance-specific information is available
AF for intraspecies differences:
5
Justification:
default factor for worker
AF for the quality of the whole database:
1
Justification:
Available data from substance fulfilling scientific principle is used
AF for remaining uncertainties:
1
Justification:
no other uncertainties needed to be considered.
Acute/short term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
3.33 mg/kg bw/day
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

Due to low vapor pressure (8.4E-7 Pa at 20 °C) and high boiling point (> 200 °C), the inhalation route is not considered to be a relevant exposure route to human. However, an inhalation DNEL, long-term systemic has been derived.

It is assumed in the Toxicokinetic Assessment based on a conservative approach that the absorption rate from oral, dermal and inhalation routes is considered to be 10%; therefore, no absorption correction is applied.

One GLP study following OECD guideline 422 was conducted to investigate the potential toxicity of alkylated naphthalene. This study identified the following NOAEL:

Parental NOAEL: 1000 mg/kg/day body weight/day.

Reproduction NOAEL: 1000 mg/kg/day body weight/day.

Developmental NOAEL: 1000 mg/kg body weight/day.

In this study, treatment of male and female Wistar rats with alkylated naphthalene by oral gavage at dose levels of 1000 mg/kg body weight/day (highest dose tested) revealed no parental toxicity or reproduction and developmental effects. Therefore, the NOAEL of 1000 mg/kg/day was selected as the basis for DNEL derivation.

Alkylated naphthalene is a close structural analog of alkylnaphthalene. The substances have similar chemical and physical properites and therefore the toxicity testing for alkylated naphthalene can be used as read-across to alkylnaphthalene.

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
6 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
150
Modified dose descriptor starting point:
NOAEC
Value:
870 mg/m³
Explanation for the modification of the dose descriptor starting point:
assuming 10% absorption via oral and 10% via inhalative route the NOAEL of 1000 mg/kg bw/d from a subacute study is corrected by multiplying with 10/10 and by division by 1.15 m3/kg/d for air consumption --> NOAECcorr = 1000 mg/kg bw/d * 10/10 / 1.15 m3/kg/d = 870 mg/m3.
AF for dose response relationship:
1
Justification:
not required, starting point is NOAEC
AF for differences in duration of exposure:
6
Justification:
based on the subacute study
AF for interspecies differences (allometric scaling):
1
Justification:
not required due to route-to-route extrapolation
AF for other interspecies differences:
2.5
Justification:
default factor for remaining differences
AF for intraspecies differences:
10
Justification:
for general population, a default AF of 10 is to be used
AF for the quality of the whole database:
1
Justification:
not required
AF for remaining uncertainties:
1
Justification:
not required
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.67 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
600
Modified dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
oral to dermal
AF for dose response relationship:
1
Justification:
NOAEL is used as the starting point
AF for differences in duration of exposure:
6
Justification:
based on the subacute study
AF for interspecies differences (allometric scaling):
4
Justification:
rats are used in the animal test
AF for other interspecies differences:
2.5
Justification:
no other substance-specific data are available.
AF for intraspecies differences:
10
Justification:
for general population, a default factor of 10 is used.
AF for the quality of the whole database:
1
Justification:
available data from substance fulfill the scientific principles
AF for remaining uncertainties:
1
Justification:
no other uncertainties need to be considered
Acute/short term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.67 mg/kg bw/day
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.67 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
600
Modified dose descriptor starting point:
NOAEL
Value:
1 000 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
no route to route
AF for dose response relationship:
1
Justification:
NOAEL is used as the starting point
AF for differences in duration of exposure:
6
Justification:
based on a subacute study
AF for interspecies differences (allometric scaling):
4
Justification:
rats are used in the animal test
AF for other interspecies differences:
2.5
Justification:
no other substance-specific information are available
AF for intraspecies differences:
10
Justification:
default factor for general population
AF for the quality of the whole database:
1
Justification:
available data from substance fulfill scientific principle is used
AF for remaining uncertainties:
1
Justification:
no other uncertainties needed to be considered.
Acute/short term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.67 mg/kg bw/day
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population

Due to low vapor pressure (8.4E-7 Pa at 20 °C) and high boiling point (> 200 °C), the inhalation route is not considered to be a relevant exposure route to human. However, an inhalative DNEL for systemic long-term toxicity was derived.

It is assumed in the Toxicokinetik assessment based on a conservative approach that the absorption rate from oral, dermal and inhalative route is considered to be 10%. Thus the NOAEL inhalative and dermal, derived by route to route extrapolation, have not been adjusted accordingly.

One GLP study following OECD guideline 422 was conducted to investigate the potential toxicity of alkylated naphthalene and identified NOAEL:

Parental NOAEL: 1000 mg/kg/day

Reproduction NOAEL: 1000 mg/kg/day

Developmental NOAEL: 1000 mg/kg body weight/day.

In this study, treatment of male and female Wistar rats with alkylated naphthalene by oral gavage at dose levels up to 1000 mg/kg body weight/day revealed no toxicity effects. At 1000 mg/kg, no toxicologically relevant effects were noted in any of the parameters.

Therefore, the NOAEL of 1000 mg/kg/day was selected as the basis for DNEL derivation.